Phase 3 study shows aQIVc demonstrated superior immunogenicity against influenza strains in adults 50 and older, with ...
Velocity Clinical and Stitch expand partnership across 70+ sites, achieving a 9-point reduction in no-show rates and boosting ...
FDA clears Prelude's PRT13722 Phase 1 trial in HR-positive breast cancer, advancing the oral KAT6A degrader toward patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results